Bavarian Nordic has already secured a sizeable portion of revenue for 2025 through orders for its mpox/smallpox vaccine, but ...

STOCKHOLM - 15 November 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) today publishes its Interim Report - January-September 2024. The full report is available on the Company's website.

One expert has given their view on this stock. The post Is this beaten-down ASX healthcare share a bargain buy now? appeared ...